These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29659751)

  • 21. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
    Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
    Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up.
    Wei L; Xie X; Liu J; Zhao Y; Chen W; Zhao C; Wang S; Liao X; Shou Q; Qiu Y; Qiao Y; Saah AJ
    Vaccine; 2019 Jun; 37(27):3617-3624. PubMed ID: 30122646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.
    Kojic EM; Kang M; Cespedes MS; Umbleja T; Godfrey C; Allen RT; Firnhaber C; Grinsztejn B; Palefsky JM; Webster-Cyriaque JY; Saah A; Aberg JA; Cu-Uvin S
    Clin Infect Dis; 2014 Jul; 59(1):127-35. PubMed ID: 24723284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine.
    Schlecht NF; Masika M; Diaz A; Nucci-Sack A; Salandy A; Pickering S; Strickler HD; Shankar V; Burk RD
    JAMA Netw Open; 2019 Oct; 2(10):e1914031. PubMed ID: 31651968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
    ; Dillner J; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Joura EA; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Maansson R; Lu S; Vuocolo S; Hesley TM; Barr E; Haupt R
    BMJ; 2010 Jul; 341():c3493. PubMed ID: 20647284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Human Papillomavirus Vaccine: Current Perspective and Future Role in Prevention and Treatment of Anal Intraepithelial Neoplasia and Anal Cancer.
    Mensah FA; Mehta MR; Lewis JS; Lockhart AC
    Oncologist; 2016 Apr; 21(4):453-60. PubMed ID: 26961923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
    Wheeler CM; Skinner SR; Del Rosario-Raymundo MR; Garland SM; Chatterjee A; Lazcano-Ponce E; Salmerón J; McNeil S; Stapleton JT; Bouchard C; Martens MG; Money DM; Quek SC; Romanowski B; Vallejos CS; Ter Harmsel B; Prilepskaya V; Fong KL; Kitchener H; Minkina G; Lim YKT; Stoney T; Chakhtoura N; Cruickshank ME; Savicheva A; da Silva DP; Ferguson M; Molijn AC; Quint WGV; Hardt K; Descamps D; Suryakiran PV; Karkada N; Geeraerts B; Dubin G; Struyf F;
    Lancet Infect Dis; 2016 Oct; 16(10):1154-1168. PubMed ID: 27373900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Papillomavirus Vaccination Prior to Loop Electroexcision Procedure Does Not Prevent Recurrent Cervical High-grade Squamous Intraepithelial Lesions in Women Living With Human Immunodeficiency Virus: A Randomized, Double-blind, Placebo-controlled Trial.
    Firnhaber C; Swarts A; Jezile V; Mulongo M; Goeieman B; Williams S; Faesen M; Michelow P; Wilkin T
    Clin Infect Dis; 2021 Oct; 73(7):e2211-e2216. PubMed ID: 32975556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of polymerase chain reaction of high-risk human papilloma virus in the screening of high-grade squamous intraepithelial lesions in the anal mucosa of human immunodeficiency virus-positive males having sex with males.
    Hidalgo-Tenorio C; Rivero-Rodriguez M; Gil-Anguita C; Esquivias J; López-Castro R; Ramírez-Taboada J; de Hierro ML; López-Ruiz MA; Martínez RJ; Llaño JP
    PLoS One; 2015; 10(4):e0123590. PubMed ID: 25849412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.
    Beachler DC; Kreimer AR; Schiffman M; Herrero R; Wacholder S; Rodriguez AC; Lowy DR; Porras C; Schiller JT; Quint W; Jimenez S; Safaeian M; Struijk L; Schussler J; Hildesheim A; Gonzalez P;
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26467666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine-preventable anal infections by human papillomavirus among HIV-infected men who have sex with men.
    Giuliani M; Latini A; Colafigli M; Benevolo M; Rollo F; Zaccarelli M; Giuliani E; Moretto D; Giglio A; Rezza G; Cristaudo A; Donà MG
    Future Microbiol; 2018 Oct; 13():1463-1472. PubMed ID: 30311788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.
    Deshmukh AA; Chiao EY; Cantor SB; Stier EA; Goldstone SE; Nyitray AG; Wilkin T; Wang X; Chhatwal J
    Cancer; 2017 Dec; 123(23):4709-4719. PubMed ID: 28950043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
    Huh WK; Joura EA; Giuliano AR; Iversen OE; de Andrade RP; Ault KA; Bartholomew D; Cestero RM; Fedrizzi EN; Hirschberg AL; Mayrand MH; Ruiz-Sternberg AM; Stapleton JT; Wiley DJ; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Cuzick J; Garland SM; Kjaer SK; Bautista OM; Haupt R; Moeller E; Ritter M; Roberts CC; Shields C; Luxembourg A
    Lancet; 2017 Nov; 390(10108):2143-2159. PubMed ID: 28886907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV Vaccine Slashes Rates of Oral Infection.
    Cancer Discov; 2017 Jul; 7(7):OF6. PubMed ID: 28526738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.
    FUTURE II Study Group
    N Engl J Med; 2007 May; 356(19):1915-27. PubMed ID: 17494925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.
    Villa LL; Costa RL; Petta CA; Andrade RP; Ault KA; Giuliano AR; Wheeler CM; Koutsky LA; Malm C; Lehtinen M; Skjeldestad FE; Olsson SE; Steinwall M; Brown DR; Kurman RJ; Ronnett BM; Stoler MH; Ferenczy A; Harper DM; Tamms GM; Yu J; Lupinacci L; Railkar R; Taddeo FJ; Jansen KU; Esser MT; Sings HL; Saah AJ; Barr E
    Lancet Oncol; 2005 May; 6(5):271-8. PubMed ID: 15863374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance.
    King EM; Gilson R; Beddows S; Soldan K; Panwar K; Young C; Jit M; Edmunds WJ; Sonnenberg P
    Sex Transm Infect; 2015 Jun; 91(4):284-6. PubMed ID: 25887283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of high-risk human papillomavirus genotype and human immunodeficiency virus DNA in anal high-grade and low-grade squamous intraepithelial lesions.
    Shiramizu B; Liang CY; Agsalda-Garcia M; Nagata I; Milne C; Zhu X; Killeen J; Berry JM; Goodman MT
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):178-81. PubMed ID: 22816619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years.
    Yoshikawa H; Ebihara K; Tanaka Y; Noda K
    Cancer Sci; 2013 Apr; 104(4):465-72. PubMed ID: 23331518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.